
BMEA
Healthcare · Biotechnology · $42.3M market cap
$0.5822+0.02 (+3.5%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -5.2% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 10, 2026 | After the close | -0.18 | -0.09 | +50.0% |
| Aug 5, 2026 | After the close | -0.21 | -0.12 | +42.9% |
| May 11, 2026 | After the close | -0.19 | -0.17 | +10.5% |
| Mar 25, 2026 | Time not confirmed | -0.22 | -0.12 | +45.6% |
| Nov 4, 2025 | After the close | -0.29 | -0.24 | +17.2% |
| Aug 5, 2025 | After the close | -0.51 | -0.51 | 0.0% |
| May 5, 2025 | After the close | -0.60 | -0.80 | -33.3% |
| Mar 31, 2025 | Time not confirmed | -0.91 | -0.81 | +11.2% |
| Oct 29, 2024 | After the close | -0.91 | -0.91 | 0.0% |
| Jul 31, 2024 | After the close | -1.09 | -1.03 | +5.5% |
| May 2, 2024 | After the close | -0.93 | -1.09 | -17.2% |
| Jan 9, 2024 | After the close | -0.85 | -0.98 | -15.3% |
| Oct 30, 2023 | After the close | -0.83 | -0.80 |
Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity. It's lead clinical program's drug candidates are COVALENT-111 and COVALENT-112, which has completed Phase II clinical trials of icovamenib for the treatment of Type 1 and Type 2 diabetes; COVALENT-211, which is in Phase II clinical trial of…
| +3.6% |
| Jul 31, 2023 | After the close | -0.88 | -0.70 | +20.5% |
| May 2, 2023 | After the close | -0.81 | -0.98 | -21.0% |
| Mar 28, 2023 | After the close | -0.81 | -0.86 | -6.2% |
| Nov 7, 2022 | After the close | -0.64 | -0.78 | -21.9% |
| Aug 1, 2022 | After the close | -0.61 | -0.59 | +3.3% |
| May 16, 2022 | Before the open | -0.53 | -0.56 | -5.7% |
| Feb 28, 2022 | After the close | -0.45 | -0.51 | -13.3% |
| Nov 3, 2021 | Before the open | -0.40 | -0.43 | -7.5% |
| Aug 11, 2021 | After the close | -0.20 | -0.33 | -65.0% |
| May 27, 2021 | After the close | -0.14 | -0.49 | -250.0% |